TOPNIVO - A safety study of Nivolumab in Patients with Recurrent and/or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): first results on behalf of the Unicancer Head&Neck Group and the GORTEC.

C. Even, A. Daste, E. Saada-Bouzid, J. Fayette, M. Kaminsky-Forrett, S. Zanetta, A. Prevost, G. Lefebvre, C. Borel, D. Cupissol, F. Huguet, J. Delord, N. Baste Rotllan, J. Delaye, I. Jallut, N. Vintonenko, J. Bourhis, J. Guigay, M. Texier, A. Auperin

Annals of Oncology (2018) 29 (suppl_8): viii372-viii399. 10.1093/annonc/mdy287